Ascentage Pharma

About:

Ascentage is a clinical-stage biopharmaceutical company that develops drugs for the treatment of cancer.

Website: http://www.ascentagepharma.com

Top Investors: Takeda, Oriza Seed Capital (Oriza Yuandian), BioVenture, ArrowMark Partners, Oriza Holdings

Description:

Ascentage Pharma develops novel small-molecule therapies for cancer, hepatitis B, and age-related diseases. They have developed a pipeline of seven drug candidates that disrupt complex and difficult-to-target protein-protein interactions and are next-generation tyrosine kinase inhibitors.

Total Funding Amount:

$312M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Suzhou, Jiangsu, China

Founded Date:

2009-01-01

Contact Email:

bd(AT)ascentagepharma.com

Founders:

Dajun Yang, Ming Guo

Number of Employees:

101-250

Last Funding Date:

2024-06-20

IPO Status:

Public

© 2025 bioDAO.ai